uniQure (QURE) EBT (2016 - 2026)
uniQure's (QURE) quarterly EBT came in at -$53.0 million in Q1 2026, down 22.96% year-on-year from -$68.9 million in Q1 2025, and down 29.38% quarter-over-quarter from -$41.0 million in Q4 2025.
uniQure (QURE) EBT (2016 - 2026) Analysis & Trends
uniQure's EBT history runs 11 years deep, the most recent figure standing at -$53.0 million for Q1 2026.
- On a quarterly basis, EBT fell 22.96% year-over-year to -$53.0 million in Q1 2026; TTM through Mar 2026 was -$203.2 million, a 5.6% increase from a year earlier, with the FY2025 full-year figure at -$193.3 million, up 18.47% from the prior year.
- EBT retreated to -$53.0 million in Q1 2026 per QURE's latest filing, from -$41.0 million in the prior quarter.
- Across five years, EBT topped out at $6.6 million in Q4 2022 and bottomed at -$89.6 million in Q3 2023.
- The 5-year median for EBT is -$53.0 million (2026), against an average of -$54.0 million.
- Across the five-year window, EBT sank 1163.21% in 2023 and jumped 50.46% in 2024, its largest moves.
- Year by year, EBT stood at $6.6 million in 2022, then sank by 1163.21% to -$70.2 million in 2023, then retreated by 3.18% to -$72.4 million in 2024, then soared by 43.37% to -$41.0 million in 2025, then dropped by 29.38% to -$53.0 million in 2026.
- Per Business Quant, the three latest QURE EBT figures stand at -$53.0 million (Q1 2026), -$41.0 million (Q4 2025), and -$71.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | uniQure | 2.42 Bn | 2.42 Bn | 3.34 Mn | -53.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.05 Mn |
| Dec 31, 2025 | -41.00 Mn |
| Sep 30, 2025 | -71.90 Mn |
| Jun 30, 2025 | -37.29 Mn |
| Mar 31, 2025 | -43.14 Mn |
| Dec 31, 2024 | -72.41 Mn |
| Sep 30, 2024 | -44.41 Mn |
| Jun 30, 2024 | -55.35 Mn |
| Mar 31, 2024 | -64.96 Mn |
| Dec 31, 2023 | -70.17 Mn |
| Sep 30, 2023 | -89.64 Mn |
| Jun 30, 2023 | -68.31 Mn |
| Mar 31, 2023 | -78.43 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Sep 30, 2022 | -48.19 Mn |
| Jun 30, 2022 | -39.38 Mn |
| Mar 31, 2022 | -47.29 Mn |
| Dec 31, 2021 | 7.87 Mn |
| Sep 30, 2021 | -36.44 Mn |
| Jun 30, 2021 | 402.73 Mn |